Sean Laaman
Stock Analyst at Morgan Stanley
(4.71)
# 648
Out of 5,116 analysts
625
Total ratings
58.9%
Success rate
11.7%
Average return
Main Sectors:
Stocks Rated by Sean Laaman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMAB Genmab | Reiterated: Hold | $57 | $53.63 | +6.28% | 2 | Nov 6, 2026 | |
| ONC BeOne Medicines AG | Reiterated: Buy | $425 → $465 | $406.96 | +14.26% | 14 | Nov 6, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $255 → $272 | $192.28 | +41.46% | 3 | Nov 6, 2026 | |
| ACAD Acadia Pharmaceuticals | Rated: Hold | $28 | $21.23 | +31.89% | 15 | Nov 5, 2026 | |
| SDGR Schrödinger | Rated: Hold | $17 → $29 | $29.82 | -2.75% | 5 | Nov 5, 2026 | |
| DNLI Denali Therapeutics | Reiterated: Buy | $40 → $42 | $20.07 | +109.27% | 11 | Nov 4, 2026 | |
| AXSM Axsome Therapeutics | Rated: Hold | $247 → $249 | $132.37 | +88.11% | 12 | Nov 3, 2026 | |
| BMRN BioMarin Pharmaceutical | Rated: Buy | $122 → $119 | $56.03 | +112.39% | 13 | Nov 3, 2026 | |
| JAZZ Jazz Pharmaceuticals | Rated: Buy | $314 → $319 | $234.76 | +35.88% | 20 | Nov 3, 2026 | |
| NBIX Neurocrine Biosciences | Rated: Hold | $183 → $185 | $164.63 | +12.37% | 23 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $273 | $256.82 | +6.30% | 3 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $87 → $88 | $74.29 | +18.45% | 9 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $53 → $60 | $69.57 | -13.76% | 21 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1,140 → $1,190 | $927.21 | +28.34% | 15 | Oct 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $13 | $2.04 | +537.25% | 6 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $43 | $30.99 | +38.75% | 6 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $90 → $92 | $78.91 | +16.59% | 14 | Oct 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5.3 → $5.9 | $3.52 | +67.61% | 6 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3 | $2.29 | +31.00% | 8 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $17 | $9.52 | +78.57% | 11 | Oct 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $70 | $49.43 | +41.61% | 1 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $11.31 | +165.25% | 11 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $10 | $10.17 | -1.67% | 9 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $93 | $75.99 | +22.38% | 14 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 | $5.90 | +442.37% | 2 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $21 | $14.41 | +45.73% | 8 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $22 | $13.06 | +68.45% | 3 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $21 | $6.93 | +203.03% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $93 → $105 | $103.63 | +1.32% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.30 | $2.82 | n/a | 19 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $12.05 | n/a | 1 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.80 → $3.95 | $5.21 | n/a | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $235.30 | n/a | 13 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33.70 | $34.75 | n/a | 16 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $310.00 | $202.04 | n/a | 68 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33.60 → $31.65 | $20.06 | n/a | 34 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25.38 → $24.14 | $45.66 | n/a | 18 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26.73 → $28.73 | $48.45 | n/a | 5 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $276.00 → $256.00 | $155.47 | n/a | 21 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1.30 | $0.50 | n/a | 29 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.15 → $7.35 | $6.76 | n/a | 21 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.45 → $1.65 | $0.74 | n/a | 15 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48.34 → $47.10 | $21.44 | n/a | 10 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53.60 → $51.60 | $55.75 | n/a | 27 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2.70 → $2.75 | $1.74 | n/a | 13 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.75 | n/a | 2 | Aug 24, 2021 |
Genmab
Nov 6, 2026
Reiterated: Hold
Price Target: $57
Current: $53.63
Upside: +6.28%
BeOne Medicines AG
Nov 6, 2026
Reiterated: Buy
Price Target: $425 → $465
Current: $406.96
Upside: +14.26%
Revolution Medicines
Nov 6, 2026
Reiterated: Buy
Price Target: $255 → $272
Current: $192.28
Upside: +41.46%
Acadia Pharmaceuticals
Nov 5, 2026
Rated: Hold
Price Target: $28
Current: $21.23
Upside: +31.89%
Schrödinger
Nov 5, 2026
Rated: Hold
Price Target: $17 → $29
Current: $29.82
Upside: -2.75%
Denali Therapeutics
Nov 4, 2026
Reiterated: Buy
Price Target: $40 → $42
Current: $20.07
Upside: +109.27%
Axsome Therapeutics
Nov 3, 2026
Rated: Hold
Price Target: $247 → $249
Current: $132.37
Upside: +88.11%
BioMarin Pharmaceutical
Nov 3, 2026
Rated: Buy
Price Target: $122 → $119
Current: $56.03
Upside: +112.39%
Jazz Pharmaceuticals
Nov 3, 2026
Rated: Buy
Price Target: $314 → $319
Current: $234.76
Upside: +35.88%
Neurocrine Biosciences
Nov 3, 2026
Rated: Hold
Price Target: $183 → $185
Current: $164.63
Upside: +12.37%
Nov 2, 2026
Rated: Buy
Price Target: $273
Current: $256.82
Upside: +6.30%
Oct 30, 2026
Reiterated: Buy
Price Target: $87 → $88
Current: $74.29
Upside: +18.45%
Oct 30, 2026
Rated: Hold
Price Target: $53 → $60
Current: $69.57
Upside: -13.76%
Oct 23, 2026
Rated: Buy
Price Target: $1,140 → $1,190
Current: $927.21
Upside: +28.34%
Oct 22, 2026
Reiterated: Buy
Price Target: $18 → $13
Current: $2.04
Upside: +537.25%
Oct 22, 2026
Reiterated: Hold
Price Target: $43
Current: $30.99
Upside: +38.75%
Oct 20, 2026
Rated: Buy
Price Target: $90 → $92
Current: $78.91
Upside: +16.59%
Oct 16, 2026
Rated: Hold
Price Target: $5.3 → $5.9
Current: $3.52
Upside: +67.61%
Oct 14, 2026
Reiterated: Sell
Price Target: $3
Current: $2.29
Upside: +31.00%
Oct 12, 2026
Reiterated: Hold
Price Target: $17
Current: $9.52
Upside: +78.57%
Oct 5, 2026
Initiated Coverage: Buy
Price Target: $70
Current: $49.43
Upside: +41.61%
Sep 15, 2026
Reiterated: Buy
Price Target: $30
Current: $11.31
Upside: +165.25%
Aug 17, 2026
Rated: Hold
Price Target: $10
Current: $10.17
Upside: -1.67%
Aug 17, 2026
Rated: Buy
Price Target: $93
Current: $75.99
Upside: +22.38%
Aug 17, 2026
Rated: Buy
Price Target: $32
Current: $5.90
Upside: +442.37%
Aug 17, 2026
Rated: Hold
Price Target: $21
Current: $14.41
Upside: +45.73%
Aug 17, 2026
Rated: Buy
Price Target: $22
Current: $13.06
Upside: +68.45%
Aug 17, 2026
Rated: Hold
Price Target: $21
Current: $6.93
Upside: +203.03%
Aug 7, 2026
Rated: Buy
Price Target: $93 → $105
Current: $103.63
Upside: +1.32%
Aug 28, 2025
Reiterated: Buy
Price Target: $3.30
Current: $2.82
Upside: n/a
Jul 2, 2025
Initiated Coverage: Hold
Price Target: $16
Current: $12.05
Upside: n/a
Feb 12, 2025
Reiterated: Hold
Price Target: $3.80 → $3.95
Current: $5.21
Upside: n/a
Aug 1, 2024
Rated: Hold
Price Target: n/a
Current: $235.30
Upside: n/a
Jun 24, 2024
Reiterated: Buy
Price Target: $33.70
Current: $34.75
Upside: n/a
Jun 12, 2024
Reiterated: Buy
Price Target: $310.00
Current: $202.04
Upside: n/a
May 22, 2024
Reiterated: Buy
Price Target: $33.60 → $31.65
Current: $20.06
Upside: n/a
Apr 9, 2024
Reiterated: Hold
Price Target: $25.38 → $24.14
Current: $45.66
Upside: n/a
Mar 22, 2024
Reiterated: Hold
Price Target: $26.73 → $28.73
Current: $48.45
Upside: n/a
Mar 21, 2024
Reiterated: Sell
Price Target: $276.00 → $256.00
Current: $155.47
Upside: n/a
Feb 28, 2024
Reiterated: Sell
Price Target: $1.30
Current: $0.50
Upside: n/a
Feb 27, 2024
Reiterated: Hold
Price Target: $8.15 → $7.35
Current: $6.76
Upside: n/a
Feb 26, 2024
Reiterated: Buy
Price Target: $1.45 → $1.65
Current: $0.74
Upside: n/a
Jan 12, 2024
Reiterated: Buy
Price Target: $48.34 → $47.10
Current: $21.44
Upside: n/a
Nov 28, 2023
Reiterated: Hold
Price Target: $53.60 → $51.60
Current: $55.75
Upside: n/a
Aug 28, 2023
Reiterated: Sell
Price Target: $2.70 → $2.75
Current: $1.74
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: n/a
Current: $13.75
Upside: n/a